Gilead Sciences
Member: Gold
Since: 17.03.2014
Since: 17.03.2014
2, Rizountos & Thrakis Street, GR-167 77 Helliniko, Athens, Greece
-
28.09.2020European Commission Grants Marketing Authorization for Jyseleca®
(Filgotinib) for the Treatment of Adults With Moderate to Severe Active Rheumatoid Arthritis -
27.07.2020Gilead Sciences Secures Exclusive Option to Acquire Tizona Therapeutics for $300 Million
Gilead Research and Development Funding to Accelerate Tizona’s First-in-Class Pipeline -
26.02.2020Gilead Sciences Initiates Two Phase 3 Studies of Investigational Antiviral Remdesivir for the Treatment of COVID-19
U.S. FDA Grants Investigational New Drug Authorization to Study Remdesivir for the Treatment of COVID-19 -
09.01.2020Gilead Sciences Licenses Portfolio of HIV Antibodies From The Rockefeller University
These investigational agents have potential for use in HIV long-acting therapies for treatment and prevention, as well as cure strategies -
24.10.2019
- MORE